Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ribosomal A-site (aminoacyl site) of the large ribosomal subunit (50S in bacteria) is a critical functional region where the incoming aminoacyl-tRNA binds to deliver an amino acid for incorporation into the growing polypeptide chain [Wilson, 2014, Nature Reviews Microbiology]. Located adjacent to the peptidyl transferase center (PTC), this site ensures the correct positioning of the tRNA for peptide bond formation [Polikanov et al., 2014, Molecular Cell]. It is a major target for several classes of antibiotics, including oxazolidinones (e.g., linezolid), lincosamides (e.g., clindamycin), and pleuromutilins (e.g., lefamulin), which disrupt bacterial protein synthesis [StatPearls, 2023]. By binding to the A-site, these drugs can physically block the entry of tRNA or induce conformational changes that halt translation [Dunkle et al., 2010, Science]. Because of the structural similarities between bacterial ribosomes and human mitochondrial ribosomes, drugs targeting this site can sometimes cause off-target toxicity, such as myelosuppression or neuropathy [Bancroft et al., 2010, Antimicrobial Agents and Chemotherapy]. Understanding the molecular architecture of the A-site is essential for developing new antimicrobial agents to combat multi-drug resistant bacterial strains [Poehlsgaard & Douthwaite, 2005, Nature Reviews Microbiology].
Inhibition of bacterial protein synthesis by binding to the 23S rRNA within the A-site of the 50S subunit, thereby preventing the proper positioning of aminoacyl-tRNA or inhibiting the peptidyl transferase reaction [Wilson, 2014; StatPearls, 2023].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal A-site of the large ribosomal subunit (50S A-site).